Howmedica Osteonics has built a focused portfolio defined by strategic positioning. Their patents carry blocking references that can constrain how competitors innovate around related technologies, and that signal stands as the most defining dimension of their IP profile. Deep family structures extend protection around each core invention. Half of their patents reach the high-value threshold, and citations arrive at a meaningful pace. Their commercial performance shows consistent growth. Howmedica Osteonics operates as a wholly owned subsidiary of Stryker Corporation, filing its patents in its own name.
